Alzheimer Disease and Dementia Archives

NAMS 2022

Unique Alzheimer Disease Risk Factors Found in Postmenopausal Women

By

Jessica Nye, PhD

October 19, 2022

Cardiovascular and genetic risk factors may predict decreased brain volume in Alzheimer disease-specific brain regions in high-risk postmenopausal women.

Neurology Information Center

Biomarker Discovery: Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

By

Nicola Davies, PhD

October 13, 2022

A biomarker for both ALS and FTD, 2 neurological disorders that share clinical, genetic, and pathological traits, can help signal disease onset and the progression of degeneration.

Neurology Information Center

Study Confirms Benefits of Lecanemab in Early Alzheimer Disease

By

Diana Ernst, RPh

October 3, 2022

Lecanemab is a humanized monoclonal antibody that works by selectively binding to, neutralizing and eliminating soluble toxic amyloid beta aggregates.

News

Hospital-Treated Infections Earlier in Life Tied to Alzheimer, Parkinson Disease Risk

September 28, 2022

Association found for Alzheimer and Parkinson disease cases diagnosed before 60 years of age

Geriatrics Information Center

Daily Multivitamin May Protect Against Cognitive Decline in Older Adults

September 22, 2022

Compared with placebo, daily multivitamin-mineral supplementation resulted in a statistically significant benefit on global cognition.

Neurology Information Center

AAPA to Develop Cognitive Assessment Toolkit for Alzheimer Disease

By

Kristin Della Volpe

September 21, 2022

The cognitive assessment toolkit for early recognition of Alzheimer disease is being developed by the AAPA in collaboration with the Cleveland Clinic and PA Foundation.